MoneyWorks4Me

Sequent Scientific informs about disclosure

21 Jul 2020 Evaluate

Sequent Scientific has informed that the Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Agnus Holdings.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1378.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..